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EXECUTIVE SUMMARY
Improving Care and Advancing Performance 
Measurement with Registries Data  
The Institute of Medicine (IOM) has 
recommended creating a “Learning Health Care 
System” that would include the capacity for 
learning more quickly and effectively from the 
delivery of health care. An infrastructure capable 
of supporting rapid learning could meet critical 
needs for better evidence in, at a minimum, three 
areas: measuring the quality and cost of health 
care; comparative clinical effectiveness research; 
and medical product safety surveillance.
Patient registries — databases of clinical 
information critical to evaluating care processes 
and outcomes — can play a vital role in 
measuring quality and cost. However, as the 
role of registries is often limited by significant 
shortcomings in their current design and 
function, they must be adapted and expanded to 
meet changing needs.
Several challenges exist in leveraging registries to 
achieve better performance measurement. The 
time and expense of linking administrative and 
clinical data have been questioned because most 
currently endorsed measures that would use a 
new, hybrid database require elements from only 
one of the datasets. There is still a significant 
lack of measures that require both clinical and 
administrative data elements. 
Several physician groups, integrated delivery 
systems, and health information exchanges have 
reported adopting or creating their own internal 
registries. National (external) registries may 
have limited use if they cannot interface with 
administrative or medication data in the same 
way internal registries can. Furthermore, while 
external registries contain information that can 
lead to improved quality of care, they must be 
linked to claims data to achieve the breadth of 
information that internal registries can provide. 
Allowing this linkage can raise legal concerns 
related to patient privacy. 
Additionally, using registries to advance 
performance measurement and ultimately 
improve care will involve finding solutions to 
what are currently common registry limitations. 
These include:
•	 Standardizing data elements and definitions 
across registries that address the same 
disease or treatment areas;
•	 Developing a uniform method of patient 
identity management;
•	 Helping registries actively interoperate with 
electronic health records systems;
•	 Standardizing methodologies for sampling, 
data quality assurance, and risk adjustment;
•	 Standardizing linkage methods;
•	 Ensuring high provider participation across 
these programs; and
•	 Guaranteeing that providers and data users 
are confident registries are sustainable.  
This paper describes short-term solutions for 
leveraging both administrative and registry data 
to make additional performance results available, 
as well as longer-term solutions to further 
increase the utility of registries for performance 
measurement and other purposes. While these 
recommendations are based on experience 
with cardiovascular disease registries, they can 
be applied to other clinical areas and are also 
broadly relevant across the health care system.
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GETTING TO A HIGH-VALUE HEALTH CARE SYSTEM
The High-Value Health Care (HVHC) Project is working to make valid, timely, and consistent 
information about the quality and cost of health care widely available in the United States.  As 
part of this effort, the Engelberg Center is developing strategies for combining clinical informa-
tion with administrative data to provide more valid and comprehensive measures of the quality 
of care.  The objectives for these new measures, which would address both internal and external 
uses of information, include:
• Enhancing the availability and use of performance measures for quality improvement pro-
grams, resulting in higher-quality care;
• Fostering development of performance-based financing for individual providers and institu-
tions, providing financial incentives to encourage the best possible care; and
• Improving public transparency about the health care system, not only to allow patients to 
make better informed decisions about choice of providers or therapies, but also to result in 
more informed actions by policymakers and regulatory bodies.
HVHC is an initiative of the Quality Alliance Steering Committee (QASC), a collaborative effort 
aimed at implementing measures to improve the quality and efficiency of health care across the 
United States. The QASC is comprised of existing and emerging sector-specific quality alliances, 
as well as leaders among physicians, nurses, hospitals, health insurers, consumers, accrediting 
agencies and the public sector. Together, these stakeholders are working to ensure that quality 
measures are constructed and reported in a clear, consistent, and person-focused way to inform 
consumer and employer decision-making, as well as the efforts of practitioners to improve care 
that is delivered. QASC will also help coordinate and build the initial components of an infra-
structure to collect health care quality and cost data nationwide.
The High-Value Health Care Project is supported by the Robert Wood Johnson Foundation. 
INTRODUCTION
The Institute of Medicine (IOM) has 
recommended creating a “Learning Health Care 
System” that would include the capacity for 
learning more quickly and effectively from the 
delivery of health care. An infrastructure capable 
of supporting rapid learning could meet critical 
needs for better evidence in, at a minimum, three 
areas: measuring the quality and cost of health 
care; comparative clinical effectiveness research; 
and medical product safety surveillance.  
In this paper, we focus on the first of those 
three areas. We examine the critical role that 
patient registries — databases of clinical and 
other information, such as patient racial and 
ethnic identifiers that are critical to evaluating 
care processes and outcomes — can play in 
measuring quality and cost. We find that the 
role of registries is often limited by significant 
shortcomings in their current design and 
function, and they must be adapted and 
expanded to meet changing needs.
The increasing use of national registry data for 
provider reimbursement and public reporting 
will inevitably lead to discussions about their 
ownership and control. While it is important 
to determine the direction of data repositories 
that traditionally have been under the exclusive 
control of professional organizations, this paper 
does not take up the broader issue of the role of 
stakeholders — such as health plans, public and 
private health care purchasers, and consumers.  
This issue will arise in the future, however, as the 
demand increases for the public benefits that 
registry data provide. 
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Clinical data allow precise characterization of 
a patient’s condition and the ability to group 
patients by the severity of their disease, but 
these data are not easily accessible and often 
are too narrowly focused on one disease or 
procedure to allow for comprehensive, patient-
centered performance measurement.  While 
administrative data, usually from insurance 
claims, are more comprehensive and follow 
patients over time across care settings and 
different medical providers, such data lack 
clinical details like patient risk factors, disease 
severity, or clinical outcomes. Combining 
administrative and clinical data allows for more 
sophisticated and comprehensive performance 
measurement. 
In order to make effective use of both 
administrative data sources, such as insurance 
claims, and clinical data housed in registries, the 
Engelberg Center is piloting feasible short-term 
approaches for leveraging both data sources to 
make additional performance results available. In 
addition, we have identified longer-term solutions 
to further increase the utility of registries for 
performance measurement and other purposes.  
While the recommendations in this paper are 
based on our experience with cardiovascular 
disease registries, they can be applied to other 
clinical areas and are also broadly relevant across 
the health care system.  Additionally, this paper 
provides the Quality Alliance Steering Committee 
with recommendations regarding how registries 
can play an important role in performance 
measurement and in the evolving national health 
information technology (IT) infrastructure.
Identifying Short- and Long-Term Solutions
Linking clinical data from registries with 
claims data can support better coordinated, 
more patient-centric care, as well as better 
performance measurement in the short term. 
This strategy requires the periodic creation 
of a linked dataset. Since claims and clinical 
registry data usually do not contain a common, 
unique identifier, patients in the two data sets 
have to be matched based on the probability 
that the patient identified in a given registry 
record represents the same patient in a claims 
database record.  One must judge, for example, 
whether the patient identified in the registry by 
name, date of birth, medical facility, etc. is the 
same patient reflected in the claims database 
with the same or similar name, date of birth, etc. 
As the accuracy and reliability of data linkage 
methodologies have improved over time, this 
short-term strategy of data linkage is increasingly 
appealing as a support for quality improvement 
efforts and performance measurement.
The Engelberg Center has been engaged in a 
series of “proof of concept” activities in the area 
of data linkage, or integration, and its role in 
supporting quality improvement and producing 
more valid and comprehensive performance 
measures. Activities have included soliciting input 
from key stakeholders regarding a number of key 
issues: how useful the measures derived from 
linked data can be, how feasible it is for others to 
replicate the data linkage, and whether there is a 
business case to support the continued financing 
of this approach. 
Based on the content of those discussions 
and the Engelberg Center’s work with 
cardiovascular disease registry owners, we make 
recommendations in each of the following areas:
•	 The lack of nationally-endorsed performance 
measures that take full advantage of linked 
administrative/clinical data;
•	 Growing challenges to participation in 
specialty society-based national registry 
programs from provider-based “home-
grown” registries; 
•	 Impediments to data linkage posed by 
differing interpretations of the Health 
Insurance Portability and Accountability Act 
(HIPAA); and
•	 Use of registries to assess racial and ethnic 
disparities in access to and quality of care.
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The paper concludes by addressing challenges 
and opportunities for long-term efforts to 
create ideal registries that also meet evolving 
performance measurement needs.  While current 
options are limited to probabilistic matching 
of large databases, more long-term strategies 
will be available in the future to accomplish 
the same objectives of quality improvement 
and performance measurement through the 
integration of clinical and administrative data. 
One such cost-effective solution will be real-time 
data acquisition from the patient encounter. For 
example, when a patient receives treatment, 
various combinations of administrative and 
clinical data elements would be transmitted 
concurrently to payers, registries, and other 
authorized repositories as appropriate.  This 
strategy supplies information to a registry in a 
manner timely enough to support and improve 
patient care — through decision support tools, 
improved care coordination, etc. It also allows 
all data elements to be used in determining 
the numerators and denominators for quality 
measures, while still residing behind the firewalls 
of data repositories — such as the claims 
databases of health insurance plans.  This 
solution helps to eliminate HIPAA-related issues 
regarding patient privacy, as well as problems 
in linking patient records through probabilistic 
linkage.
As we look toward a future in which electronic 
health records (EHR) are ubiquitous, registries 
will continue to play a critical role, as 
performance measurement often will require 
organizing particular data elements from the 
vast amount of information contained in an EHR 
system. 
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WHAT ARE REGISTRIES?
The Agency for Healthcare Research and 
Quality’s (AHRQ) handbook, “Registries for 
Evaluating Patient Outcomes: A User’s Guide,” 
defines patient registries as a collection of 
uniform data (clinical and other) used to evaluate 
outcomes in specific populations for scientific, 
clinical or policy purposes.1 
Registries collect data on populations defined 
by clinical conditions or diseases, procedures 
or treatment, or resource use. For example, the 
Society of Thoracic Surgeons (STS) National 
Database collects data on patients who undergo 
all forms of thoracic surgery, including coronary 
artery bypass graft (CABG) surgery. In addition, 
registries can support a number of important 
functions at the individual patient, care team, and 
organization levels, including: 
•	 Collecting and storing data on a patient’s 
diagnosis and treatment that can be analyzed 
and referred to as needed; 
•	 Generating outputs that facilitate care 
delivery and coordination at the individual 
patient level, such as decision support, 
patient reports, reminders, notifications, lists 
for proactive care, and educational content; 
•	 Providing tools to assist with population 
management, quality improvement, 
and quality reporting – for example, risk 
adjustment, trend analysis, population 
views, benchmarks, and quality report 
transmissions; and
•	 Supporting essential research applications 
such as comparative effectiveness studies.
Current Registries Vary Significantly 
Not all of these functions are currently performed 
by all registries, and some could be performed 
through other data sources, such as EHRs, that 
may eventually become the primary source 
of data for registry functions. This variation is 
driven by several factors, including technical 
limitations. All registries collect and clean data 
to some extent, and many provide population-
based reports to their participants, although this 
practice can vary significantly. 
A major area of differentiation is the degree 
to which registries provide care delivery and 
coordination functions at the individual patient 
level. Not surprisingly, an important determinant 
of whether patient care/coordination functions 
will be implemented is where in the patient-
clinician workflow the data are actually collected, 
analyzed, and reported.  To be useful for 
individual care purposes, registries need to have 
data available for processing and a means to 
deliver information to the provider team close 
in time to the care episode.  For example, the 
American Heart Association’s (AHA) Get With 
The Guidelines program, the American College of 
Cardiology’s (ACC) CathPCI registry, and the STS 
CABG database provide quality measurement 
and improvement tools to participants.  However, 
because data are collected through third-party 
systems that periodically upload data to a central 
repository, these registries do not provide the 
same patient-specific information at the point 
of care — unless the third party system chooses 
to implement algorithms based on the data 
collected.  
Registries are not only a mechanism to collect 
quality and performance data, but in several 
cases they are associated with progressive 
performance improvement by their participants. 
Of particular interest are those registries 
that use reporting and other tools for rapid 
cycle quality improvement.  In a randomized 
study of “low-intensity” continuous quality 
improvement interventions conducted within the 
359 institutions in the STS database network, 
Ferguson et al. demonstrated a significant 
difference in improvement for sites receiving 
additional continuous quality improvement 
support including reporting.2 
Several large, national studies3,4,5 have 
demonstrated how providers have significantly 
impacted their performance through 
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participation in a national registry.  In a head-
to-head study that used hospital data from 
Hospital Compare, an online database created 
by the Centers for Medicare & Medicaid Services 
(CMS) and the Department of Health and Human 
Services (HHS), 223 hospitals using the AHA Get 
With The Guidelines (GWTG)-Coronary Artery 
Disease (CAD) registry fared significantly better 
in measures of guideline compliance than 3,407 
non-GWTG-CAD hospitals.6  The availability of 
both guidelines information and real-time data 
for rapid cycle quality improvement through the 
Learning from Experience
Piloting efforts to link registry and claims data to calculate performance measures
The Engelberg Center has been piloting a short-term strategy for better performance 
measurement.  This effort has involved linking clinical data from registries with claims data 
to create a hybrid database that can be used to calculate more valid and comprehensive 
measures of the quality and cost of medical care.  The projects use claims data to look 
forward and backward in time from a particular cardiovascular procedure.  This approach 
provides useful information for improving quality and care coordination by allowing us to 
understand long-term outcomes more broadly and essential components of care in greater 
depth.  Also, both projects support longer-term goals of improving the specificity and 
clinical relevance of the measures to be included in quality reports.
Two examples of Engelberg Center projects are:
• With the American College of Cardiology (ACC) and UnitedHealthcare, linking the 
ACC’s catheterization/percutaneous coronary intervention (cath/PCI) registry with 
UnitedHealthcare claims.  This project applies quality measures to linked data to assess 
care that occurs after the patient’s catheterization.  For example, to determine: Did the 
patient need a transfusion before discharge? Did the patient need a non-invasive stress 
test within six months after PCI?
• With the Society of Thoracic Surgeons (STS) and WellPoint, linking the STS coronary 
artery bypass graft registry with WellPoint claims to assess care after open-heart 
surgery.  For example, to determine: Had the patient suffered a prior heart attack while 
on beta-blocker medication?  Did the patient remain on lipid-lowering drugs for six 
months after surgery?
registry itself was thought to be an important 
reason for the difference in results.  
Registries in cardiovascular disease originate 
from a number of different sources, including 
professional societies, national voluntary 
health agencies, hybrid payer/provider 
entities, integrated delivery systems, regions/
communities, and government entities. 
Some coordination of registry development 
occurs across several organizations — such as 
harmonizing definitions between ACC and STS 
registries — although these efforts remain limited. 
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HOW CAN REGISTRIES IMPROVE IN THE SHORT TERM?
Linking Registries with Administrative Claims 
for Better Performance Measurement: Current 
Impediments and Recommendations to Overcome 
Them 
Data integration involves linking clinical data 
from sources like registries (information that is 
clinically detailed but limited in both time period 
and scope) with administrative data such as 
insurance claims, which include entire periods 
of coverage for the insured across different 
providers and care settings but contain limited 
clinical detail.  The Engelberg Center’s recent 
experiences with a short-term strategy for better 
performance measurement highlight several 
challenges in pursuing this approach.  These 
are described below, along with recommended 
solutions for registry owners, policymakers, and 
others. 
1. Lack of Nationally-Endorsed Measures for Linked 
Registry and Claims Data
The time and expense of linking administrative 
and clinical data for more valid and 
comprehensive performance measurement 
has been questioned because most currently 
endorsed measures that would use a new, hybrid 
database require elements from only one of the 
datasets.  Although more than 70 “clinically-
enriched” measures have been endorsed or are 
pending endorsement by the National Quality 
Forum, there is still a significant lack of measures 
that require both clinical and administrative data 
elements.  In large part this is because technical 
challenges — including coding systems, data 
submission practices and patient and provider 
identifiers — hinder more rapid development 
and implementation of such measures.  It will 
be important to address such issues in order for 
data linkage to find a sustainable business case; 
also necessary will be more nationally-endorsed 
measures that require linked data and prove 
useful to providers, patients, health plans, and 
purchasers.
Current quality and cost measures for 
cardiovascular care are often derived from only 
one source of readily available data and usually 
focus on the technical process of care.  These 
measures, based on insurance claims, address 
the issue of whether or not the appropriate 
procedures were followed for certain patients. 
However, the simplicity of the data source can 
often lead to a measure that lacks the precision 
necessary for further analysis and interpretation. 
Interviews conducted in early 2009 with 
key quality leaders and clinical experts in 
cardiovascular care consistently found that 
patient care after an inpatient stay is poorly 
measured.  While follow-up care and care 
coordination for up to 90 days post-discharge 
are key to overall care quality, these components 
of the care process are reflected in very few 
existing measures. 
Respondents also observed that existing 
measures do not support the goal of a more 
patient-centered care system.  Very few 
measures directly address issues most important 
to patients — including access, outcomes, and 
quality of life or health status.  In addition, they 
raised questions regarding both patient and 
clinician confidence in the measures themselves.  
General unease regarding sources of the 
measures and also about the proprietary nature 
or transparency of some measures presents a 
significant challenge to the development of more 
meaningful, consumer-friendly performance 
information.
Current data also do not adequately support 
robust cost-of-care measurement for a number 
of reasons:
•	 Current cost-of-care measures, typically 
based on claims data, may be subject to 
the common limitations of claims data with 
respect to accuracy and completeness — 
exclusion of out-of pocket expenses, services 
provided under benefit “carve-outs”, etc.
•	 Ideal cost-of-care measures would identify 
clinically homogeneous patient cohorts and 
measure the costs of care associated with 
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treating those patients.  Administrative data 
alone cannot identify clinically homogenous 
patient populations for certain conditions 
because of their inability to measure 
underlying clinical variability among patients. 
For example, among patients diagnosed with 
breast cancer, clinical stage information is 
critical for cohort identification since costs 
of care can vary significantly from Stage I 
patients to Stage II, III, or IV patients.  Or, in 
the case of patients with acute myocardial 
infarction (AMI), administrative data cannot 
distinguish the ST segment elevation 
myocardial infarction (STEMI) patients 
requiring a specific type of intervention from 
non-STEMI events.  This is very important 
in predicting the costs associated with a 
patient’s care.
•	 Most cost-of-care measures rely on a risk 
adjustment model to account for the effect 
a patient’s co-morbid conditions have on the 
costs of care for the condition of interest. 
For example, to measure the costs of care 
associated with treating a patient’s coronary 
artery disease, risk adjustment would 
typically account for whether or not a patient 
also has congestive heart failure (CHF), which 
can be indicated by the presence of CHF 
diagnosis codes in claims data.  However, 
many risk adjustment models could be 
improved by accounting for the severity of 
these co-morbid conditions.  For example, 
the seriousness of the patient’s co-morbid 
CHF could be gauged using other clinical 
information like the patient’s left ventricular 
ejection fraction.  The availability of this kind 
of information about a wide range of clinical 
conditions could make the measure’s risk 
adjustment model significantly more accurate 
than using claims data alone.
•	 Some cost-of-care measures are calculated 
on a per-capita basis (all costs for care 
over a time period, typically one year) 
while other cost-of-care measures consider 
only condition-related resource use.  While 
attributing cost to an individual illness is 
challenging for any patient with multiple 
conditions, the lack of clinical information 
in claims makes it particularly difficult to 
determine whether a treatment was more 
directly related to the condition of interest 
or to another of the patient’s co-morbid 
conditions.  For example, whether lipid-
lowering medications are related to diabetes 
or to hypertension in a patient with both 
conditions.
A hybrid database that includes both claims and 
clinical data would provide distinct advantages 
by addressing the shortcomings of using either 
type of data alone:  
•	 Improve Precision.  Linked data could be 
used to broaden, narrow, or subdivide the 
measured population to make the target 
population more homogeneous or to 
determine with certainty whether a particular 
procedure or therapy is relevant to a given 
measure.  In the context of appropriateness-
of-care measures, linked data can better 
identify patients for whom a particular 
elective procedure may not have been 
advised appropriately or other patients for 
whom a particular procedure should have 
been advised.  Clinical registry data could 
be used in conjunction with claims to more 
effectively risk-adjust measures and address 
a principal objection among physicians who 
say that measures of cost and efficiency do 
not effectively account for variation in patient 
morbidity or relative risk.  Claims have the 
advantage of including services delivered 
across many different care settings and 
allowing us to look forward and backward in 
time from a registry-based procedure.
•	 Facilitate Quality Improvement Efforts. 
Performance measures built on linked 
data would permit adjustments for patient 
treatment adherence and provide the 
comprehensive data necessary to provide 
actionable steps for improving quality. 
Those measures and the data systems to 
report them could be leveraged secondarily 
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— not only to reform incentives inherent in 
current provider reimbursement systems, 
but also to align them more closely with 
the goals of providing higher-quality care.  
Such examples could be through pay-for-
performance arrangements or the formation 
of accountable care organizations. 
•	 Support Patient-Centered Care.  Integrating 
administrative and clinical registry data 
would permit development of measures of 
utilization and variation in resource use as 
well as measures of outcomes and provider 
performance.  These measures would 
take into account information going both 
downstream (follow-up procedures and 
evaluations) and upstream (pre-procedure 
diagnostics) in order to provide a more 
complete picture of care at the patient level. 
Recommendations: Nationally-Endorsed Measures
1. Measure developers and the National Quality 
Forum (NQF) should focus on and receive 
more support for the identification and 
endorsement of performance measures 
relying on combined sources (e.g, clinical 
registry data combined with physician, 
hospital, and pharmacy claims, laboratory 
data, etc.). 
2. AHRQ and/or CMS should establish funding 
mechanisms for measure development using 
hybrid (linked) databases.
3. Existing national registry programs should 
develop flexible data infrastructures to 
prepare them to accommodate — in a cost-
effective, provider-friendly and real-time 
environment — data inputs from multiple 
sources that may be required for the next 
generation of performance measures. 
2. “Home-Grown” Registries and National Registry 
Programs  
A number of physician groups, integrated 
delivery systems (IDS), and health information 
exchanges (HIE) have reported adopting or 
creating registries for chronic diseases including 
coronary artery disease.  Some of the larger IDS 
and physician groups report developing registries 
that interface with their practice management 
systems, EHR systems, and network labs.  Others 
have worked with commercial vendors to specify 
and purchase registry “add-ons” that interface 
with a multitude of data sources.    
For providers, these registries support clinical 
practice by collecting, aggregating, and 
integrating clinical, administrative, and patient 
demographic data.  Depending on the provider 
organization, these processes support reporting 
that can be used in patient management, quality 
improvement, and/or performance assessments. 
Aggregated data in registries have been used 
to identify patients who are non-adherent to 
evidence-based disease management protocols. 
Examples include patients whose lab values are 
in poor control, who are missing lab results, or 
who have not been seen during recommended 
follow-up intervals. 
A provider can also access a registry to review 
patients’ records, including individual patient 
and lab values.  Registries can be used to 
generate monthly reports to give feedback to 
both providers and patients, and the information 
would be used to provide targeted intervention 
to patients — such as recruiting high-risk patients 
for more aggressive disease management 
programs.
These registries also provide an array of 
functions to support payers’ need for timely 
information.  For payers, registries may be 
used as a tool to generate automatic reports of 
provider performance.  The reports, which can 
provide a snapshot of and serve as the basis 
for determining incentive payments, are more 
accurate and comprehensive when the registries 
are populated with both clinical and claims data. 
Kaiser Permanente (KP) is one organization 
that uses both external registries and their 
own internal, “home-grown” systems.  Because 
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of KP’s robust EHR system, internal registries 
provide more timely information, making it 
more actionable for internal applications such as 
planning, business decision-making, developing 
risk calculators for physician decision support 
tools, and tracking patients for “care gaps.” 
Physicians can receive instant feedback and have 
immediate access to data for research, and as a 
result are more willing to support and participate 
in the registries.  KP leaders feel that this sort of 
immediate feedback is key to garnering physician 
support and changing physician behavior. 
KP also participates in some overlapping external 
registries (for the same conditions), primarily 
to provide the organization with benchmarking 
data.  Furthermore, these external registries may 
be able to support the organization in other ways 
such as submitting data to the CMS Physician 
Quality Reporting Initiative (PQRI), Bridges to 
Excellence, and other payer-sponsored incentive 
programs.  For organizations such as KP, external 
registries may have limited use if they cannot 
interface with KP administrative or medication 
data in the same way internal registries can. 
In addition, the nature of KP’s integrated system 
and registries allows internal users to look at 
long-term outcomes for some patients.  For 
example, researchers can view data on heart 
disease patients who received medical treatment, 
then catheterization and stent placement, and 
finally a CABG procedure.  This is currently 
not possible with external registries, not only 
because of the separation of care components 
in different registries, but also sometimes due 
to different standards for coding, definitions, or 
data submission. 
Recommendations: “Home-Grown” Registries 
1. National registry owners should 
engage provider organizations that are 
developing their own internal registries 
to better understand the evolving needs 
— such as functionalities and ease of use 
as part of routine care — that are the 
impetus for registry development.
a. National registries should re-
orient data output and input 
systems to facilitate the more 
transactional or on-demand 
functionalities providers are 
seeking, as well as develop 
longer-term monitoring functions 
for quality improvement and 
outcomes measurement.
b. Among the functionalities 
national registries should seek to 
integrate into their data reporting 
outputs are decision-support, 
links to practice management 
systems, and public reporting.
2. Over time, if the growth of internal 
registries for on-demand functions 
increases, national registry programs 
might re-evaluate their futures in the 
clinical world.  For example, their niche 
could be providing national benchmarks, 
standards, and best practices for 
registries rather than more detailed QI 
information; diffusing evidence-based 
practice guidelines; and supporting 
registry programs for relatively low-
volume services that make sense only 
when aggregated nationally.
3. Effects of the HIPAA Privacy Rule
While clinical registries contain information that 
can lead to improved quality of care, allowing 
access to this information can raise legal 
concerns related to patient privacy.  Privacy 
regulations under HIPAA, or the Privacy Rule,7 
govern how health plans and other entities8 may 
use and disclose protected health information 
(PHI).  
The Privacy Rule requires that PHI not be used or 
disclosed without an individual’s authorization, 
unless that use or disclosure is specifically 
permitted under the rule.  Health plans that 
disclose PHI to “business associates” — for 
example, to a claims processing service or 
data analysis company — must have a written 
agreement with that associate containing a 
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number of specific provisions for safeguarding 
the information.  Specific restrictions are often 
placed on the organizations both giving and 
receiving the information.  Safeguarding PHI 
requires understanding these restrictions, which 
may or may not allow the linkage of PHI to claims 
data for quality improvement activities.
In the Privacy Rule, a distinction also is drawn 
between use of PHI to improve a health plan 
or provider’s own health care operations — 
this is allowed as long as proper safeguards 
are taken — and using it for broader research 
purposes, such as studying quality improvement 
initiatives for the industry at large.  Although the 
Privacy Rule defines research as “a systematic 
investigation, including research development, 
testing, and evaluation, designed to develop or 
contribute to generalizable knowledge,”9 the 
line between quality improvement and research 
can sometimes be hard to determine.  However, 
it is an important distinction, because in many 
cases explicit permission must be obtained from 
patients to use their information for research, and 
there is currently no uniform mechanism for this. 
While there may be policy implications that 
argue for allowing for quality improvement-
related research to be done through a broader 
approval process under the Privacy Rule, the 
entity responsible for enforcing the Privacy Rule 
— the HHS Office for Civil Rights (OCR) — has 
not provided such leeway at this point.  This 
lack of clarity may discourage providers from 
disclosing PHI to registries.
Currently, the Privacy Rule provides for a 
number of ways by which a registry can use or 
disclose PHI for research in addition to obtaining 
individual patient consent.  These include the 
following: 
•	 De-identified Information.  One approach, 
and the most conservative, is for the 
registry to de-identify the PHI before 
using or disclosing the information for 
research purposes.  Once de-identified, the 
information, by definition, is no longer PHI, 
and no longer subject to the Privacy Rule.
•	 Limited Data Set.  A health plan can use 
or disclose a limited data set for research 
purposes.  Therefore, some entities 
maintaining clinical registries enter into 
a specific data use agreement with the 
health plan, in addition to the basic business 
associate agreement, permitting use or 
disclosure of the information for research 
purposes.  Provided that the registry 
complies with the data use agreement, this 
approach likely complies with the Privacy 
Rule and does not violate the terms of the 
agreements between the parties.
•	 IRB Waiver of Authorization.  A health 
plan is permitted to use or disclose PHI for 
research purposes if it obtains appropriate 
documentation of an institutional review 
board’s waiver of the authorization 
requirement.  The Privacy Rule does not 
contain a specific provision to allow a 
business associate to use or disclose PHI 
for research purposes with an IRB waiver 
of authorization.  Permitting the IRB waiver 
to include business associates — a decision 
also under the purview of OCR — could 
result in a compliant approach that does not 
entail removing certain identifiers to create a 
limited data set or de-identifying data, a task 
that can be extraordinarily time consuming 
and costly. 
There is some debate about whether or how the 
Privacy Rule allows PHI to be linked to claims 
data in order to further analyze the data.  If the 
purpose of such a linkage is to obtain knowledge 
that can be generalized, the use or disclosure 
likely would be considered research under the 
Privacy Rule.  Still, it is less clear whether the 
information would also be useful in promoting 
quality of care for the patients involved 
themselves.
Lack of clarity around the permissibility of linking 
clinical registry data with claims data using 
probabilistic matching has resulted in a number 
of varying interpretations of the Privacy Rule, as 
follows: 
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•	 Data linkage is not permitted, even if using 
a limited data set and creating a data 
use agreement, because the probabilistic 
matching re-identifies the limited data set. 
As a result, the use and disclosure actually 
involves PHI and thus, violates the data use 
agreement.
•	 Provided that the data linkage involves only 
the use or disclosure of a limited data set, 
that use or disclosure is consistent with the 
data use agreement.  (Proponents of this 
position recognize that it walks a fine line 
because of the potential for the probabilistic 
matching to re-identify the information, 
depending on the contents of the limited 
data set.)  
•	 Linking PHI with claims is acceptable with 
an IRB waiver of authorization that permits 
research, provided that the PHI is not merged 
to create a separate database.  
The need to obtain institutional review board 
(IRB) approval and/or patient consent can often 
stop data linkage initiatives before they begin. 
While many registries may be exempt from 
IRB review under the Common Rule, this is not 
universally true, and different institutions may 
interpret the rules differently.  A recent IOM 
report recommended clarifications in both HIPAA 
and IRB issues related to research and registries, 
as well as significant HIPAA modifications 
to better support a learning healthcare 
environment.10   
Recommendations: HIPAA 
1. The federal government should pursue a 
policy of public education regarding what 
is and is not acceptable under HIPAA.  This 
should include clearer guidance from OCR 
on when it is permissible under the Privacy 
Rule to link clinical registries with claims 
data and/or any business associate or data 
use agreements between the parties — such 
as for comparative effectiveness research 
or in the release of summary information 
like quality measure numerators and 
denominators.
2. End users of linked datasets should 
collaborate in development of a number 
of important and illustrative “straw-man” 
scenarios, designed to be representative of 
questions commonly asked by the end users’ 
legal counsels, which could be submitted 
to OCR.  The agency could then publicly 
respond to these in an effort to provide 
guidance as to whether or not particular 
situations violate HIPAA.
3. Depending on the interpretations of the 
law offered by OCR, Congress should 
act to revise HIPAA in such a way that it 
permits the linking of datasets as part of 
research activities designed to support 
quality improvement, provided reasonable 
precautions are taken to ensure patient 
privacy is preserved.
4. Addressing Disparities: Collecting Race, Ethnicity, 
and Language Data
Disparities in quality of care based on race or 
ethnicity are well documented.  For example, 
African-American men are 73 percent less 
likely than white men to receive an implantable 
cardioverter-defibrillator, a life-saving technology 
for those with the highest risk for sudden cardiac 
death.11  African Americans are also less likely to 
use revascularization procedures and even when 
clinically indicated, they are more likely not to 
receive the procedure.12  
Health care disparities have been found in 
other minority populations as well.  The 2009 
National Health Disparities Report found that the 
proportion of hospital patients with heart failure 
who received the recommended hospital care 
was lower for Hispanics and American Indians/
Alaskan Natives than for whites.13  
In order to more fully document, assess, 
and improve disparities in care, the IOM has 
called for increased efforts among health care 
organizations to acquire and report race and 
ethnicity data.  Currently, 22 states require that 
hospitals report race and ethnicity data.14  But 
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unlike state requirements for hospitals, only two 
states, California and Massachusetts, passed 
legislation requiring health plans to collect and/
or report such data.15,16  Hospitals and community 
health centers have had higher response rates, 
but health plans have been limited in their ability 
to acquire directly-collected race and ethnicity 
identifiers from members.  In addition, even when 
such data are acquired they are often stored 
in warehouses that are incompatible with data 
sources containing performance information. 
Also, stratifying administrative data by race, 
ethnicity or language categories further limits the 
analyses that can be conducted, since the sample 
sizes in each category become too small to 
allow for appropriate comparisons and statistical 
power.  These limitations make identifying 
disparities and determining strategies to reduce 
them extremely challenging.
The use of registry data can help address health 
care disparities in a number of ways, including: 
•	 Using registries as a clinically rich source 
of standardized data across geographically 
diverse service-provider settings.  One 
major challenge to understanding health 
care disparities over geographically diverse 
populations is an inability to compare 
patients of varying racial and ethnic 
backgrounds because data are collected 
in a multitude of ways and with differing 
categories.  Registries may be one way to 
acquire standardized race/ethnicity data 
from patients, which can be compared across 
geographic locations.  
•	 Integrating indirectly estimated and directly 
collected race/ethnicity data to assess 
population-level health care equity.  The 
Engelberg Center and The RAND Corporation 
have engaged a multi-state pilot to evaluate 
the feasibility of health plans using RAND’s 
indirect estimation algorithm to determine 
race/ethnicity composition among members 
where directly collected data are unavailable. 
This pilot also will evaluate the feasibility of 
integrating directly collected and indirectly 
estimated data to assess population-level 
disparities.  
•	 Using race/ethnicity data to improve 
equitable cardiac care.  Perhaps the greatest 
contribution registries will have in the effort 
to eliminate health care disparities is in their 
ability to proactively engage patients in 
their own care with decision support tools 
and educational materials.  Further, patient 
reports and other tools offered to providers 
— and perhaps to payers — that highlight 
areas of disparities will be essential in 
advancing culturally appropriate care for all 
patients. 
 Recommendations: Addressing Disparities 
1. Users of registry data should leverage non-
clinical data elements, such as race, ethnicity, 
and language (REL) data, to further inform 
quality improvement and research activities, 
such as reduction of care disparities.
2. The IOM recently developed 
recommendations for advancing standard 
race/ethnicity categories across health care 
sectors.  Such standardization is imperative 
to the development of comparable disparity 
information from variable data sources.
3. To the extent a registry’s REL data are limited 
or the registry does not have such data 
elements, efforts should be made to link 
the registry’s data to REL data from one or 
more other sources.  The registry also should 
encourage participating providers to submit 
this information directly in the future.
4. Earlier, we recommended that registries 
should increase and augment their current 
functionalities to be more appealing to 
providers and provider groups going forward. 
Registries also should ensure these additional 
functionalities can be used to support 
aspects of the care process that can address 
disparities, including cultural competency 
support for providers and a variety of 
languages in patient support decision tools.  
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LONG-TERM STRATEGIES: WHAT MAKES AN “IDEAL” 
REGISTRY?
Long-term strategies to support patient care and 
performance measurement — whether real-time 
clinical data acquisition from the point-of-care 
or queries made through EHR systems — will 
eliminate the need for large-scale data linkage 
projects, but not for the clinical data that reside 
in registries.  Even when linkage to registries is 
no longer an issue, registry owners and users will 
face general challenges in making these sources 
of clinical data more useful.  If we create a new 
registry today taking into account current and 
future needs, how should it be designed in the 
context of the “ideal” registry for the future?
Regarding the recently released interim final 
rule for meaningful use of EHR technology by 
the HHS Office of the National Coordinator 
(ONC), the functionalities of an ideal registry can 
further enhance or supplement EHR systems, 
and therefore help eligible providers and 
facilities meet such requirements.  For example, 
the meaningful use incentive program requires 
reporting of performance metrics and other 
structural indicators to illustrate “meaningful 
use” of health information technology to improve 
care coordination and improve population 
health.  The ability to aggregate data from 
multiple data sources in a registry, such as 
EHRs, that can be queried by chronic disease 
population, by provider, and by patient affords 
the user an enhanced functional capacity to 
sufficiently address meaningful use priority areas. 
For additional details on how an ideal registry 
supports priority areas of meaningful use, see 
Appendix 1. 
Few registries today have all of the 
characteristics of an ideal registry.  A review of 
cardiovascular registries, for example, identifies 
many strengths and limitations.  Some registries 
collect highly uniform data that can be used 
for risk adjustment, but have limited follow-
up for long-term outcomes.  Many are used in 
hospitals with EHR systems, but are generally 
not interoperable with those systems on a real-
time basis.  Examples provided in Table 1 vary in 
levels of provider participation, use of nationally-
standardized data sets, quality assurance 
methods, and many other ideal characteristics.  
In addition, most registries have focused 
on high-volume, adult hospital admission 
diagnoses or procedures.  With some important 
exceptions, registries do not typically collect 
information on less common diseases, or even 
common cardiovascular disease as managed 
by primary care clinicians.  While some national 
organizations have launched or are planning 
to launch ambulatory-based registries — such 
as the ACC PINNACLE Program and AHA 
Features of an Ideal Registry
The ideal registry can facilitate the exchange 
and use of health information for direct 
patient care and performance measurement 
and reporting.  It collects uniform data on 
risk factors, treatments, and outcomes at key 
points for a particular disease or treatment. 
It obtains the data from multiple sources 
and across care settings.  It leverages health 
information technology systems through 
interoperability, and other data sets through 
linkage.  
The ideal registry uses standardized methods 
to assure that the patients sampled are 
representative of the care provided; that 
the data collected are of sufficiently high 
quality to be used for decision-making 
and payment; and, that the information 
collected is comparable across providers. 
Such a registry provides feedback at the 
patient and population levels, guides 
quality improvement, supports comparative 
effectiveness research, and can facilitate 
quality reporting to third parties. Importantly, 
an ideal registry will have a high level of 
participation by providers and patients and 
have a long-term, sustainable business model.
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GWTG-Outpatient — few cardiovascular disease 
registries currently exist in the ambulatory area, 
and those that do have limited participation.  
Long-term follow-up is generally limited in 
many of the large, professional society-driven 
registries.  However, there is growing experience 
with linking these registries to administrative 
datasets to obtain longer-term outcomes.17,18,19
Building ideal registries will involve finding 
solutions to what are currently common 
limitations: 
Data elements and definitions should be 
standardized across relevant conditions.
Current lack of standardization makes it 
difficult to link data or to compare results 
across registries.  Developing common, core 
data standards that can be applied consistently 
is the clear solution.  Although this is slowly 
occurring for some conditions, efforts could 
be significantly accelerated in cardiovascular 
disease if stakeholders moved more 
aggressively towards developing core datasets 
through multi-stakeholder consortia for each 
Table 1.  Examples of cardiovascular disease registries and their relative strengths and limitations
Sponsoring
Organization 
Clinical
Condition 
Registry Type Example of 
Strength 
Example of 
Limitation 
Professional 
society (e.g. 
ACC, STS) 
Acute Coronary 
Syndrome
  
Hospitalization Collects uniform 
data
Limited patient 
follow-up  
Cardiovascular 
Surgery
Procedure & 
Hospitalization
Risk Adjusted Administrative 
burden of 
collecting a 
large volume of 
data
Voluntary 
Membership 
Organization 
(e.g. AHA) 
Stroke Hospitalization High 
participation 
Not yet 
interoperable 
with EHR 
systems 
Integrated 
delivery system 
(e.g. Maine 
Medical Center)
Heart disease 
and diabetes
Disease Extensive care 
delivery and care 
coordination 
functionalities 
Cannot provide 
external 
benchmarks  
Individual 
hospital (St. 
Elizabeth’s 
Hospital) 
Heart Failure Disease Large 
percentage of 
patients enrolled 
Non-
standardized 
data collected 
Regional/
Community 
(Wisconsin) 
Pediatric CV 
abnormalities
Disease Data from 
doctors and 
patients
Representative 
sampling 
Limited quality 
assurance, low 
participation 
Government 
agency (e.g. 
MA Dept. of 
Public Health) 
Stroke Hospitalization Mandated 
participation 
No risk 
adjustment
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condition.  A major comparative effectiveness 
research (CER) initiative —  the ACC and STS 
Collaboration on the Comparative Effectiveness 
of Revascularization Strategies (ASCERT), 
which looks at the comparative effectiveness of 
treatments for stable coronary artery disease — is 
moving forward even without current consensus 
on data strategies across registries, and will 
provide technical solutions to address a number 
of these registry data issues.
A uniform method of patient identity 
management is needed.
Since different care settings and different 
databases collect data on patients with their 
own identifiers, standardizing those identifiers 
is necessary to link data either longitudinally in 
the same database from different care settings 
or between databases.  Currently there is no 
standard, accepted way for health care entities to 
securely and smoothly share a patient identifier 
or pseudonym between them, such as when a 
patient receives care at both a hospital and an 
independent physician office practice.
Methods for secure patient identity management 
exist (e.g., PIX20) but have not been widely tested 
or deployed across registries.  Testing such 
methods in broader pilots could both standardize 
the methods and encourage implementation, 
thereby helping to bridge the critical divide in 
how data can be collected across care settings.
It may also be possible to link records without 
reliable unique identifiers — an important 
development since the nation is unlikely to get a 
single unique patient identifier in the near future. 
Some current technologies, such as “blindfolded” 
record linkage based on cryptologic techniques, 
show promise in enhancing the probability of 
successful record matches without compromising 
the privacy of patient demographic data. 
Registries should be able to actively 
interoperate with EHR systems. 
EHR usage is increasing due in part to the $19 
billion in incentive payments for adoption under 
the American Recovery and Reinvestment Act 
of 2009 (ARRA).  However, investment in health 
IT will not by itself create more willingness 
among providers to enter their information 
into more than one electronic system, such as 
both EHRs and registries.  For this reason, a 
number of groups — including the Clinical Data 
Interchange Standards Consortium (CDISC), 
Integrating the Healthcare Enterprise (IHE), and 
the Healthcare Information and Management 
Systems Society (HIMSS) — are supporting the 
concept of functional interoperability between 
EHRs and registries.  In particular, these groups 
are promoting a kind of interoperability that 
supports key functionalities typically offered by 
one system or the other and can be achieved 
in the near-term.  Also, much more effective 
movement and communication of data between 
EHRs and registries could occur if existing open 
standards are broadly adopted.  To date, these 
standards have been widely tested by many of 
the larger EHR system vendors21 and endorsed by 
the EHR vendors association,22 but have not been 
broadly adopted. 
Part of the reason for this may be the lack of a 
clear business case to implement open standards 
for EHRs and facilitate their use.  Furthermore, 
if these standards are not implemented with 
provider control of the configuration process 
— allowing them to choose which diagnosis 
codes trigger notification of a registry to 
appear in the system — it is unlikely that even 
deployment of the standards will result in 
widespread use, as customization by the EHR 
vendor would be required.  Current discussions 
regarding definitions of “meaningful use” under 
ARRA provide a unique opportunity to directly 
influence adoption of open standards as part 
of the “certification” process, and to do so in 
a manner that allows simple configurations to 
be done by the provider.  Pilot programs can 
further demonstrate how these standards can 
be easily implemented, as well as produce actual 
improvements in care based on data exchange.   
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Methodologies for sampling, data quality 
assurance, and risk adjustment should be 
standardized.
While many registries seek to collect data on 
all patients, it is unknown how many hospitals 
or practices comply with this requirement. Few 
perform audits of screening logs or provide 
sampling algorithms to assist high-volume 
centers in lowering the significant costs of 
data collection.  With respect to data quality 
assurance, defined data elements and automated 
error checking are relatively standard, but 
beyond that, there is a tremendous range in 
procedures — from relatively expensive on-
site data audits to monitoring to nothing at all. 
The impact of such variation is unknown, but 
it is difficult to compare or combine data sets 
or know the accuracy of the observations in a 
data set without standardization of methods. 
One potential solution is to seek a list of 
standard requirements for registries that will 
participate in performance measurement. 
This should be achieved through stakeholder 
and expert collaboratives.  The goal of such 
meetings would be to define minimal quality 
assurance requirements for national performance 
measurement participation with an emphasis 
on practical, clinically important issues and 
feasibility — as detailed standards may not be 
needed for every lab test, but rather just the 
important ones for a particular disease.  Once 
registries meet minimal standards, the bar can 
be raised periodically through similar meetings 
every few years.
Linkage methods should be standardized.
While linkage of data is now possible, the full 
value of data linkage will only be realized with 
adequate standardization.  Standardization 
is necessary both so that registry developers 
know what elements to include in their data sets 
for future linkage and so that reasonably high 
matching levels are routinely achieved.  
Several cardiovascular disease registries 
have been early adopters of probabilistic and 
deterministic methods to link their registry data 
to other data sources containing outcomes 
information, such as Medicare and Medicaid. 
This has been particularly important since many 
of these registries are limited in their ability to 
collect long-term outcomes data. 
Both statistical and legal issues are associated 
with such linkage efforts for performance 
measurement.  First, statistical methods have 
advanced beyond the legal framework, creating 
uncertainty about whether the extensive 
linkage activities envisioned for performance 
measurement could create privacy law violations. 
Clarification of legal safe harbors is needed 
from HHS, specifically with respect to avoiding 
unintended re-identification of patients. 
Second, for linked outcomes to be used for 
performance measurement, the accuracy of the 
linkage needs to be sufficiently high to allow 
use of the information at the accountable care 
organization or provider level.  This requires 
both standardization of matching approaches 
to improve accuracy and a clear understanding 
of the limitations of such approaches for linked 
data sets for the specific purpose of performance 
measurement.  Seeking standardization of 
linkage approaches through pilots and expert 
reviews and obtaining clarification of privacy 
issues affected by such linkage from HHS would 
greatly facilitate these efforts — unless the 
linkages took place within a secure data system 
with only summary information reported out.  
Provider participation should be consistently 
high across these programs.
Use of registries for performance measurement 
will be limited without high levels of participation 
by providers, since performance measurement is 
based on relative comparisons between providers 
or organizations rather than on absolute results. 
A provider’s decision to participate in a particular 
registry is invariably based on an assessment that 
the burdens — in this case, the costs and efforts 
of data collection and submission — are less than 
the perceived benefits. 
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A review of existing registries emphasizes that, in 
many respects, registry participation is linked to 
economic importance.  Participation is highest in 
registries where it is related to licensure or access 
to patients — for example, the Primary Stroke 
Service registry in Massachusetts that requires 
participation for ambulance diversion to the 
participating facility, or the ACC CathPCI registry 
that has mandated participation in several 
states including Massachusetts and Virginia. 
Mandates and patient access are closely followed 
in terms of their ability to encourage provider 
participation by qualification for payments, such 
as the ACC ICD Registry, which is part of the CMS 
Coverage with Evidence Development program. 
Intermediate in participation are those registries 
that offer recognition or certification, like the 
GWTG recognition awards that are published in 
U.S. News and World Report.  Those registries 
whose sole reward is quality improvement can 
be highly successful, but participation in those 
programs is generally less than registries in the 
other categories.  Finally, registries developed 
primarily for research or for the public good 
without economic rewards generally have low 
participation rates. 
In addition, future registries will have to keep 
the cost of participation low by automatically 
providing registry functions automatically as 
part of providers’ routine electronic clinical 
management systems.  Registries that do not 
build such functionalities into these existing 
systems, thus avoiding extra work for the 
provider, will not be sustainable.
To overcome these issues, it will be important 
to identify and support initiatives that can make 
participation more automated from the provider’s 
standpoint and also link participation both to 
sufficient economic incentives and to clinical 
benefits for the provider and patients.  This will 
be particularly important among some provider 
communities when data housed in registries are 
used in preparing reports on quality and cost that 
become publicly available.  Such reports should 
be as representative of the population being 
assessed as possible to enhance their validity. 
Therefore, some additional incentives might be 
required to ensure high participation in registries 
that provide data for public reporting.
Providers and users of data should be confident 
that registries are sustainable.
Finally, in order to rely on registries for 
performance measurement, both providers 
and users of performance measurement data 
must have faith that the registries to which they 
submit data will be sustained over time.  Current 
registry business models for operating registries 
vary.  The registries discussed above are based 
on a number of models, including organizational 
investment, external or industry sponsorship, user 
fees, data sales, and combinations of different 
models.  Many other registries rely on short-term 
funding sources such as grants.  If operating 
costs were to increase significantly, such as if 
a registry were required to add new standard 
quality assurance practices, some registries 
might not be able to survive financially.  
Potential solutions for this issue include 
advocating for models that provide sufficient 
incentives for participation so that high-quality 
registries with sustainable business models 
emerge.  While this sounds difficult, one current 
example of a performance measurement 
program using registry reporting is the PQRI 
registry program.  The emerging PQRI Registry 
Reporting model is highly inclusive, and any 
registry may self-nominate.  It then must meet 
specified criteria for methodology, follow 
technical requirements for data transmission, and 
agree to potential audits.  Through this inclusive 
model, CMS has accepted different measure sets 
for more than 70 registries in just two years, 
including ACC-NCDR, STS, and AHA GWTG.
The key advantage to this type of model for 
organizations that develop registries is that it 
will provide a new set of incentives for providers 
to participate in their registries. This sort of 
“automatic” reporting system — in contrast 
to the manual, claims-based alternative like 
PQRI — aligns the incentive of lower provider 
participation cost with support for a more 
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sustainable business model for registries.  The 
system’s timeliness and multiple functionalities 
also better support improvements in patient care 
using the information.  Some might argue that 
it would be advantageous for a single specialty 
society, for example, to be the national provider 
of performance measurement data; however, 
that would likely be difficult to achieve and 
might even be undesirable.  The model described 
here maintains the independence of the 
cardiovascular organization’s registry goals and, 
to the extent that performance measurement 
data requirements diverge from the goals of 
the organization’s registry or the interests of its 
participants, the registry can opt to be the data 
provider only for the measures of its choosing.
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CONCLUSION
Registries can play an important role in better 
health care performance measurement.  To 
achieve this, clinical data from registries must be 
integrated with claims data to create a hybrid 
database that can be used to improve care and, 
in turn, calculate more valid and comprehensive 
measures of the quality and cost of medical care. 
However, while clinical data from registries 
are very detailed, they are usually focused on 
one event — a procedure or a hospital stay, for 
example — and don’t include information on 
what happened to the patient before or after that 
event.  Claims data, on the other hand, include 
care delivered over time by many different 
providers in any setting, but do not contain the 
clinical detail needed to characterize the patient’s 
condition or to adequately assess their care. 
One could therefore describe registry data as 
“an inch wide and mile deep,” and claims data 
as “a mile wide and an inch deep.”  Linking these 
data sources can overcome the shortcomings 
of each to produce information that is both 
comprehensive and clinically detailed.  
Most of the registries discussed in this paper 
were created as feedback programs to serve 
retrospective quality improvement activities.  For 
example, physicians or institutions voluntarily 
subscribe, and the registry programs provide 
both periodic analysis of subscriber results 
plus benchmarking to peers elsewhere.  Levels 
of participation among eligible physicians/
institutions vary, as does the use of the data once 
they are analyzed and fed back to subscribers.
Currently, applications for registry data have 
expanded to include not only linkage to other 
databases, but also support a number of other 
applications, as outlined in Table 2. 
In order to accommodate the needs of the data 
users who will define the changing landscape of 
applications for clinical registries, current registry 
owners should also pursue two overarching 
strategies:
•	 Multi-stakeholder planning to take 
advantage of current and emerging 
opportunities.  Engage large provider groups 
that have developed their own registries in 
efforts to assess: 1) where existing national 
registry programs can provide services more 
rapidly in the care process to serve needs 
within these organizations; and, 2) where 
they can enhance complementary services 
that provider organizations cannot generate 
themselves, such as external benchmarking.
•	 Break down the silos that prevent registries 
within the same clinical area from achieving 
their potential.  Accelerate efforts to 
“harmonize” registries within clinical 
areas, such as cardiovascular disease.  For 
example, a heart disease patient being 
Types of Applications Examples
Support for care delivery Appointment/reminder systems, EHRs
Data for reimbursement arrangements Quality measures that trigger bonus 
payments
Clinical comparative effectiveness research Linking registries to administrative data and 
to other registries across the continuum of 
care for a particular condition
Table 2.  Expanded Use for Registry Data
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medically managed who has a diagnostic 
catheterization, or stenting, and then a CABG 
would appear in three different registries — 
an AHA registry for medical management, 
ACC registry for catheterization/stenting, 
and STS registry for CABG.  Although data 
definitions are becoming more standard, 
these registries do not “talk” to one another. 
This does not provide strong enough support 
for medical practice, nor does it promote 
a patient-centered “learning health care 
system” in which data better informs services 
provided to patients. 
As a catalyst to support these strategies, federal 
payment policies can substantially accelerate the 
efforts of registry owners — if those policies align 
around paying for better-documented results 
for patients based on better-integrated data 
supporting patient care.
Indeed, patient registries hold enormous 
potential as powerful tools to help measure, 
manage, and improve care.  For registries to 
fulfill their potential, stakeholders must work 
together to overcome the current limitations 
in function and flexibility.  The strategies and 
recommendations outlined in this paper — and 
summarized in Appendices 2 and 3 — provide 
a starting point for the short- and long-term 
activities that can help create a system of 
registries that support both good health and 
good health care.  
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Health Policy Priorities (Meaningful Uses)
Key Registry 
Functionalities for 
QI23
Improve 
quality, 
safety, 
efficiency, 
and reduce 
health 
disparities
Engage 
patients 
and 
families
Improve 
care 
coordination
Improve 
population 
and public 
health
Ensure 
adequate 
privacy and 
security 
protections 
for personal 
health 
information
Enroll representative 
patients, providers, 
settings
√ √ √ √
Use standardized 
data elements and 
definitions
√ √ √
Allow rapid changes 
to be made in 
response to changing 
knowledge
Assure quality of 
procedures and data
Have sufficient follow-
up to obtain relevant 
outcomes
√
Protect privacy and 
confidentiality √
Integrate and 
leverage existing data 
systems to reduce 
burden
√
Provide education/
decision support 
where feasible
√
Provide real-time 
or rapid feedback/
reports (to improve 
care and care 
coordination), 
including nationally 
endorsed measures
-	 Apply appropriate 
risk adjustment
-	 Provide relevant 
benchmarks
-	 Provide reports 
appropriate for 
different levels of 
users (e.g. doctor, 
hospital, health 
system)
√ √ √
Appendix 1.  Meaningful Use Activities 
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APPENDIX 2
Short-Term Recommendations
Issue Recommendation
1
Implement Nationally-
Endorsed Measures Based on 
Linked Administrative/Claims 
Data
 
1. NQF should maintain a focus on the endorsement of 
performance measures relying in part on clinical registry 
data (in addition to physician, hospital and pharmacy claims, 
laboratory data, etc.) and should include among their 
measure evaluation criteria the assurance that the most 
appropriate data sources have been brought to bear in each 
measure’s calculation.  For example, if a measure could be 
calculated more appropriately using linked data rather than 
administrative or clinical data alone, that should count against 
the measure in the endorsement process if its proposed 
source is either clinical or administrative data alone.
 
2. The Agency for Healthcare Research and Quality (AHRQ) 
and/or CMS should establish funding mechanisms for measure 
development using hybrid (linked) databases; and 
 
3. Existing national registry programs should develop flexible 
data infrastructure to prepare them to accommodate the next 
generation of performance measures using data elements 
from multiple sources, particularly EMRs + claims.
2
Deploy “Home-Grown” 
Registry Functionalities in 
National Registry Programs
 
1. National registry owners should engage provider 
organizations that are developing their own internal registries, 
to better understand the evolving needs, with respect to 
functionalities and ease of use, that are the impetus for 
development of new registries internally.
 
a. National registries should re-orient their data 
output systems to facilitate the more transactional or on-
demand functionalities providers are seeking, as well as 
developing longer-term monitoring functions for quality 
improvement and outcomes measurement.
 
b. Among the functionalities national registries should seek 
to integrate into their data reporting outputs are decision 
support, links to practice management systems, and public 
reporting.
 
2. National  registry programs should re-evaluate their 
futures in a clinical world where their niche might be 
providing national benchmarks (rather than more detailed QI 
information), diffusing evidence-based practice guidelines, 
and supporting registry programs for relatively low-volume 
services (e.g., pediatric neurosurgery) that make sense only 
when aggregated nationally.
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3
Clarify Applications of the 
HIPAA Privacy Rule to Data 
Linkage Activities
 
1.The federal government should pursue a policy of public 
education regarding what is and is not acceptable under 
HIPAA.
 
2. End users of linked datasets should collaborate in 
development of a number of important and illustrative “straw 
man” scenarios, designed to be representative of questions 
commonly asked by the end users’ legal counsels, which could 
be submitted to HHS-OCR.  The agency could then publicly 
respond to these in an effort to provide guidance as to 
whether or not particular situations violate HIPAA.
 
3. Depending on the interpretations of the law offered by 
HHS-OCR, Congress should act to revise HIPAA in such a 
way that it permits the linking of datasets as part of research 
activities designed to support quality improvement, provided 
reasonable precautions are taken to ensure patient privacy is 
preserved.
4
Leverage Race, Ethnicity, and 
Language Data Collected 
in Registries to Assess 
Disparities
 
1. Users of registry data should leverage non-clinical data 
elements, such as race, ethnicity, and language (REL) data, to 
further inform quality improvement and research activities, 
such as reduction of care disparities.
2. The IOM recently developed recommendations for 
advancing standard race/ethnicity categories across health 
care sectors.  Such standardization is imperative to the 
development of comparable disparity information from 
variable data sources.
3. To the extent a registry’s REL data are limited or the 
registry does not have such data elements, efforts should 
be made to link the registry’s data to REL data from one 
or more other sources.  The registry also should encourage 
participating providers to submit this information directly in 
the future.
4. Registries should ensure that augmentations to their 
current functionalities can be used to address disparities, 
including cultural competency support for providers and a 
variety of languages in patient decision support tools.
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APPENDIX 3
Long-Term Recommendations
VISION: National registries contain consistent summary information derived from 
comprehensive electronic data to support patient care in near-real time.
Issue Recommendation
1
Standardize data elements and 
definitions across most conditions
 
Efforts to developing common, core datasets could 
be significantly accelerated through multi-stakeholder 
consortia for each cardiovascular condition.
2
Develop a uniform method of patient 
identity management
 
Since different care settings and different databases 
collect data on patients with their own identifiers, 
standardizing those identifiers is necessary to link 
data either longitudinally in the same database from 
different care settings or between databases.
3
Allow registries to actively 
interoperate with electronic health 
records systems
 
While it may be difficult or impossible to achieve 
full interoperability between EHRs and registries for 
many years, a concept  of functional interoperability 
(what can be achieved today and is sufficient to 
get the job done) is emerging from groups like 
Clinical Data Interchange Standards Consortium 
(CDISC), Integrating the Healthcare Enterprise (IHE), 
and the Healthcare Information and Management 
Systems Society (HIMSS).  Pilot programs can further 
demonstrate how these standards can be easily 
implemented. 
4
Standardize current methodologies 
for data quality assurance, and risk 
adjustment
 
One potential solution is to seek a list of standard 
requirements for registries that will participate in 
performance measurement.  This can be achieved 
through end-user, stakeholder, and expert 
collaboratives.  Once registries meet minimal 
standards, the bar can be raised periodically through 
similar meetings every few years. 
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5 Standardize linkage methods
 
This requires both standardization of matching 
approaches to improve accuracy and a clear 
understanding of the limitations of such approaches 
for linked data sets for the specific purpose of 
performance measurement.  Seeking standardization 
of linkage approaches through pilots and expert 
reviews, and obtaining clarification of privacy issues 
affected by such linkage from HHS would greatly 
facilitate these efforts.
6
Encourage uniformly high 
participation by providers across 
registry programs
 
Identify and support initiatives that can link 
participation to sufficient economic incentives, as 
well as lowering the cost of participation.  This will 
be particularly important when the clinical data in 
registries are used in preparing reports on quality, 
cost, etc. that become publicly available.  Not only 
can public reporting be a disincentive for providers 
to participate in registries, but public reports should 
be as representative of the population being assessed 
as possible to enhance their validity.  Therefore, some 
additional incentive might be required to ensure high 
participation in registries that provide data for public 
reporting.
7
Create sustainable business models 
for registry programs
 
Potential solutions include advocating for models 
that provide sufficient incentives for participation so 
that high-quality registries with sustainable business 
models emerge. 
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